STOCK TITAN

Sanuwave Health (SNWV) Stock News

SNWV OTC

Welcome to our dedicated page for Sanuwave Health news (Ticker: SNWV), a resource for investors and traders seeking the latest updates and insights on Sanuwave Health stock.

SANUWAVE Health, Inc. reports company developments tied to FDA-cleared and FDA-approved directed-energy systems used in advanced wound care. The company researches, develops and commercializes non-invasive regenerative medicine technologies designed to activate biological responses for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its wound care portfolio includes the UltraMIST product line and related product candidates.

Recurring news includes quarterly and annual revenue updates, financial guidance, conference-call materials, medical-device commercialization activity and channel relationships for UltraMIST. Company updates also describe applications of its energy transfer technologies in wound healing, orthopedic and spine, aesthetic and cosmetic, and cardiac and endovascular conditions.

Rhea-AI Summary

SANUWAVE Health (OTCQB: SNWV) has formed a joint venture with MEDSTENT, S.A. to market its dermaPACE® System for treating chronic wounds in Mexico. This system, cleared by COFEPRIS, addresses diabetic foot ulcers, venous and arterial ulcers, and post-surgical wounds. The partnership aims to leverage MEDSTENT's expertise in the Mexican healthcare market to enhance access to this innovative treatment. The wound care market in Mexico is expected to grow at a CAGR of 6.72% over the next five years due to an aging population and increasing chronic wounds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.28%
Tags
none
-
Rhea-AI Summary

SANUWAVE Health, focused on advanced wound care, announced it will participate in significant medical meetings to showcase its Energy First approach with the dermaPACE® and UltraMIST® systems. Key events include DFCon20 (Oct 9-10), PRESENT e-Learning Systems (Oct 13), and The Academy of Physicians in Wound Healing Symposium (Oct 16-18). These platforms aim to educate specialists on innovative treatments for chronic wounds. The company's technologies enhance healing by combining energy transfer methods to improve patient outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
conferences

FAQ

What is the current stock price of Sanuwave Health (SNWV)?

The current stock price of Sanuwave Health (SNWV) is $16 as of May 11, 2026.

What is the market cap of Sanuwave Health (SNWV)?

The market cap of Sanuwave Health (SNWV) is approximately 133.9M.